Blog

Side Effects · 9 min read

GLP-1 Side Effects: What to Expect and How to Manage Them

A clinical guide to GLP-1 side effects — what's common, what's rare, what's serious, how long they last, and what you can do to make them manageable.

Most people who start semaglutide or tirzepatide injections experience at least one side effect in the first month. The good news is that the vast majority are mild, predictable, and temporary — and once you understand the pattern, most are very manageable. This guide walks through exactly what to expect, when to expect it, and what to do about each one.

The one-page summary

Side effectFrequencyUsually resolves within
Nausea30–45%4–8 weeks
Constipation20–25%Ongoing (manageable with diet/fiber)
Diarrhea15–20%2–4 weeks
Vomiting10–20%4–6 weeks
Fatigue10–15%2–4 weeks
Acid reflux / heartburn5–10%Ongoing (manageable)
Injection site reactions1–8%Hours to 2 days
Gallbladder problems~1–2%May require treatment
Pancreatitis<1%Requires immediate care

Most side effects follow the same curve: they peak in the first 1–2 weeks after starting the medication or after each dose increase, then gradually fade. Titration — starting low and increasing slowly — exists specifically to give your body time to adapt.

The three main GI side effects

About three out of every four side-effect reports in GLP-1 trials are gastrointestinal. This is because the medication slows stomach emptying and alters gut motility — which is part of how it works. The good news is these effects are rarely dangerous and almost always temporary.

Nausea

The most common side effect by far, affecting roughly 30–45% of users at some point. It typically starts within a few days of the first injection, peaks in the first 2–4 weeks, and subsides by week 4 or 5 as your body adjusts. This pattern may repeat itself with each dose increase, until your body adjusts to a steady maintenance dose.

What helps:

  • Eat smaller meals, more frequently. A stomach that empties slower gets full faster.
  • Eat slowly and stop eating the moment you feel full — your brain lags behind your stomach signal by 20+ minutes.
  • Avoid greasy, fried, or very rich foods, especially in the first 48 hours after each dose.
  • Stay upright after meals for at least an hour.
  • Ginger (tea, chews, capsules) has decent clinical evidence for nausea relief.
  • If severe, your provider can prescribe an anti-nausea medication (ondansetron) for the first few weeks.

When to call your provider: nausea that prevents you from keeping down water for more than 24 hours, or any nausea accompanied by severe abdominal pain (see pancreatitis below).

Constipation

Affects about 20–25% of users. Unlike nausea, constipation often persists as a mild ongoing issue rather than fading after a few weeks. This is because GLP-1 slows gut transit time as part of its core mechanism — there's no adaptation, you just manage it.

What helps:

  • Increase water intake significantly — aim for 80–100 oz/day.
  • Add soluble fiber gradually (psyllium husk / Metamucil is well-tolerated).
  • Eat more vegetables, fruit with skin, and whole grains.
  • Try an OTC stool softener or gentle laxative, such as Miralax or magnesium citrate.
  • Light daily walking (20+ minutes) meaningfully improves gut motility.
  • For stubborn cases, a stool softener (docusate) or osmotic laxative (polyethylene glycol / MiraLAX) is safe for daily use.

Diarrhea

Less common than constipation but does affect about 15–20% of users, particularly in the first 4 weeks after starting or increasing a dose. Usually resolves within a few days without intervention.

What helps:

  • Stay hydrated with electrolytes (not just water).
  • Avoid dairy, very high-fiber foods, and sugar alcohols while symptoms are active.
  • The BRAT diet (bananas, rice, applesauce, toast) is old but works.
  • Probiotic foods (yogurt, kefir) can help as you recover.

When to call your provider: diarrhea lasting more than 5 days, blood in stool, or signs of dehydration (dizziness, rapid heart rate, very dark urine).

Ready to see if you qualify?

A licensed Pallas provider can review your health history and confirm eligibility in under 2 minutes.

Start your intake →

Less common but worth knowing

Fatigue

About 10–15% of users report unusual tiredness in the first few weeks. This usually isn't directly caused by GLP-1 — it's usually a side effect of the side effects. If you're nauseated, under-eating, and slightly dehydrated, fatigue follows. It almost always improves within a month or so.

What helps:

  • Prioritize protein — at least 0.7g per pound of goal body weight, even if you're not hungry.
  • Make sure you're getting at least 1,200 calories (women) / 1,500 calories (men) even during rapid weight loss. Below that, everything suffers.
  • Check your iron, B12, and vitamin D if fatigue persists beyond a month.

Acid reflux and heartburn

Slowed stomach emptying means acid sits in your stomach longer and is more likely to reflux. Affects 5–10% of users, more commonly at higher doses.

What helps:

  • Don't lie down for at least 2 to 3 hours after eating.
  • Smaller meals.
  • Avoid common reflux triggers while on GLP-1s: coffee, alcohol, chocolate, spicy food, tomato, citrus.
  • Over-the-counter famotidine (Pepcid) is well-tolerated and highly effective. Take it 30 min before the meal most likely to trigger symptoms.

Injection site reactions

Minor redness, a small lump, or mild itching at the injection site affects 1–8% of users. These are rarely serious and typically resolve within 24–48 hours.

What helps:

  • Rotate sites. The abdomen (2+ inches from navel), outer thighs, and upper arms are all fine.
  • Let the pen sit at room temperature for 15–30 minutes before injecting (cold medication stings more).
  • Ice the area for 2–3 minutes after injection if you bruise easily.

When to call your provider: widespread hive-like rash, facial/throat swelling, or difficulty breathing — these are signs of a serious allergic reaction and require emergency care.

Rare but serious side effects

These are uncommon, but important to recognize because they require immediate medical attention.

Pancreatitis

Inflammation of the pancreas. Occurs in less than 1% of GLP-1 users, but more common in people with a history of pancreatitis or heavy alcohol use.

Symptoms:

  • Severe, persistent upper abdominal pain that may radiate to the back
  • Pain that worsens after eating
  • Nausea and vomiting that are dramatically worse than typical GLP-1 nausea
  • Fever
  • Rapid heart rate

If you experience these symptoms, stop the medication and seek medical care. Pancreatitis is treated in a hospital and requires imaging (CT or MRI) to confirm.

Gallbladder problems

Rapid weight loss (from any cause, not just GLP-1) increases the risk of gallstones. Gallbladder-related side effects occur in 1–2% of GLP-1 users, typically at higher doses and in patients losing weight quickly.

Symptoms:

  • Sudden, severe pain in the upper right abdomen
  • Pain that comes in waves and lasts 30 minutes to several hours
  • Nausea, vomiting, and sometimes fever
  • Clay-colored stools
  • Jaundice (yellowing of skin or eyes) in serious cases

Let your health care provider know right away if you experience these symptoms. Gallbladder problems sometimes require surgery or hospital care.

Thyroid concerns

GLP-1 medications carry a boxed warning about a rare type of thyroid cancer (medullary thyroid carcinoma) based on rodent studies. The link has not been established in humans, but as a precaution, GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Your intake questionnaire will screen for this.

Low blood sugar

Rare when GLP-1s are used alone for weight loss, but common when combined with insulin or sulfonylureas in diabetic patients. If you're not diabetic and not taking those medications, this is unlikely to be an issue.

The practical timeline

For most people, the common GLP-1 side effect trajectory looks like this:

Week 1

  • Starting dose: mild nausea on day 1–3, fatigue, maybe some appetite change
  • By day 5–7: most symptoms fading

Weeks 2–4

  • Mostly adjusted to starting dose
  • Appetite reduction clearly noticeable
  • Constipation may become a consistent issue — this is the time to establish hydration and fiber habits

Week 5 (first dose increase)

  • New wave of mild to moderate nausea for 2–4 weeks
  • Continue through each titration step

Month 3+

  • Side effects are less common at stable doses
  • Many people report feeling completely normal between injections
  • Weight loss continues even as side effects fade

Questions to ask your provider

If you're considering starting GLP-1 therapy, these are the side-effect-related questions worth raising during your intake:

  1. What's the titration schedule you recommend for my situation?
  2. What OTC medications can I keep on hand for day-one readiness (anti-nausea, stool softener)?
  3. What's your threshold for slowing titration if I'm struggling?
  4. How often can we message during the first 30 days?
  5. Are there red flags that should prompt me to pause injections?

At Pallas, ongoing provider messaging is included with every plan — side effects are easier to manage when you can get a real answer within hours.

Frequently asked questions

Broadly yes — they share the same GLP-1 mechanism. Tirzepatide's dual mechanism can produce slightly stronger GI effects at high doses, but in head-to-head comparisons the side-effect profiles are more similar than different. See our full semaglutide vs tirzepatide comparison for the details.

Yes. High-fat, high-sugar, or very large meals reliably worsen nausea and can trigger vomiting. Many patients learn this the hard way during the first week and naturally shift toward lighter, protein-forward eating — part of why GLP-1s work.

Alcohol can make GLP-1 side effects like nausea and acid reflux worse and increase the risk of dehydration. That said, small amounts are generally safe, but most people report decreased tolerance — alcohol hits harder and clearing it takes longer. Alcohol also increases pancreatitis risk, which is already slightly elevated on GLP-1s. Many patients naturally drink less on these medications.

No. Injected semaglutide and tirzepatide are absorbed from the tissue under your skin, not from your stomach — vomiting doesn't remove the medication, even if it happens minutes after injecting. Never repeat or "make up" an injection after vomiting; your full dose is already on board. The exception is the oral semaglutide tablet: a dose vomited soon after swallowing may be partially lost, but don't take a second tablet — message your care team and they'll tell you how to proceed. If vomiting is persistent, or you can't keep water down for more than 24 hours, contact your provider.

If you have severe nausea or vomiting that won't subside, severe abdominal pain, or signs of an allergic reaction, skip your scheduled injection and contact your provider. Don't try to "catch up" a missed dose with a double injection.

Possibly. GI side effects come from the same mechanism that causes weight loss (slowed gastric emptying, altered gut signaling). But intensity of side effects doesn't predict the magnitude of weight loss — some people lose 20%+ with minimal side effects, others experience ongoing side effects and lose only 10%.

Yes, absolutely. Weight will begin to return, but stopping is safe and many patients pause temporarily to let symptoms resolve before resuming at a lower dose. Talk to your provider first — there may be a workable compromise like slower titration.

References

This article was reviewed against the following primary sources — the FDA-approved prescribing information for the branded products and current peer-reviewed clinical guidance on managing GLP-1 side effects.

  1. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory. Am J Clin Nutr. 2025;122(1):344–367.
  2. Mehrtash F, Dushay J, Manson JE. I Am Taking a GLP-1 Weight-Loss Medication — What Should I Know? JAMA Intern Med. 2025;185(9):1180.
  3. Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated With GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2023;12(1):145.
  4. U.S. Food and Drug Administration. WEGOVY® (semaglutide) prescribing information. 2026.
  5. U.S. Food and Drug Administration. ZEPBOUND® (tirzepatide) prescribing information. 2026.
  6. Zahrawi F, Suyavaran A, Banini B, Mehal W. GLP-1 Receptor Agonism Results in Reduction in Hepatic Ethanol Metabolism. NPJ Metab Health Dis. 2025;3:36.
  7. National Institutes of Health. GLP-1 Plus Therapy Can Reduce Heavy Drinking. 2026.

Bottom line: GLP-1 side effects are predictable, mostly temporary, and usually manageable with a few simple habits. The first month is the hardest; many people report feeling normal by month two. If you're starting therapy, the single most important thing is to have a provider you can message easily during the first 30 days.

Start with a provider who answers your messages

Every Pallas plan includes ongoing provider messaging — especially helpful during the first month of titration.

Start your intake →